中西医结合治疗良性位置性眩晕合并后循环缺血  

Integrated Chinese and Western Medicine in the Treatment of Benign Positional Vertigo with Postcirculatory Ischemia

作　　者：陈丹 CHEN Dan(Department of Neurology,Panjin Central Hospital,Liaoning Province,Panjin 124010,China)

机构地区：[1]盘锦市中心医院神经内四科,辽宁盘锦124010

出　　处：《中国中医药现代远程教育》2019年第4期113-115,共3页Chinese Medicine Modern Distance Education of China

摘　　要：目的研究中西医结合用药治疗良性位置性眩晕合并后循环缺血的临床疗效及血流动力学参数的影响。方法选取2014年5月—2017年2月于我院就诊的良性位置性眩晕合并后循环缺血患者共67例,按不同用药方案将患者分为对照组(n=31例)和研究组(n=36例)。对照组患者采用甲磺酸倍他司汀治疗,研究组患者采用甲磺酸倍他司汀联合银杏叶滴丸治疗。对比2组患者临床疗效及椎动脉血流动力学参数。结果对照组治疗总有效率为45.16%(14/31),显著低于研究组治疗总有效率为94.44%(34/36),差异有统计学意义(X^2=10.458,P<0.05)。2组患者治疗前阻力指数、平均流速、舒张末期流速和峰值流速等血流动力学指标对比均无统计学差异(P>0.05),治疗后,2组各项指标均有所改善,与治疗前比较,差异有统计学意义(P<0.05),且研究组治疗后各项指标改善程度好于对照组,差异有统计学意义(P<0.05)。结论良性位置性眩晕合并后循环缺血患者治疗中,采用甲磺酸倍他司汀联合银杏叶滴丸治疗可提高临床疗效,改善血流动力学,无明显不良反应。Objective To study the clinical efficacy and hemodynamic parameters of combined Chinese and Western medicine in the treatment of benign positional vertigo with post-circulation ischemia.Methods A total of 67 patients with benign positional vertigo and post-circulatory ischemia who were treated in our hospital from May 2014 to February 2017 were enrolled.The patients were divided into control group(n=31 cases)and study group(n=36 cases)according to different medication regimens.Patients in the control group were treated with betahistine mesylate,and patients in the study group were treated with betahistine mesylate combined with ginkgo biloba pills.The clinical efficacy and vertebral hemodynamic parameters of the two groups were compared.Results The total effective rate of the control group was 45.16%,which was significantly lower than of the study group(94.44%).The difference was statistically significant(χ^2=10.458,P<0.05).There were no significant differences in the hemodynamic parameters between the two groups before treatment(P>0.05).After treatment,both groups improved and treated.Before the comparison,the difference was statistically significant(P<0.05),and the improvement of the indicators in the study group was better than that of the control group,and the difference was statistically significant(P<0.05).Conclusion In patients with benign positional vertigo and post-circulatory ischemia,treatment with betahistine mesylate combined with ginkgo biloba pills can improve clinical efficacy and hemodynamics without obvious adverse reactions.

关 键 词：良性位置性眩晕 后循环缺血 甲磺酸倍他司汀 银杏叶滴丸 

分 类 号：R743.3[医药卫生—神经病学与精神病学] R764.3[医药卫生—临床医学]